Double prophylaxis for deep venous thrombosis in patients with gynecologic oncology who are undergoing laparotomy does preoperative anticoagulation matter?

International Journal of Gynecological Cancer

Volumn 21, Issue 6, 2011, Pages 1131-1134

  Whitworth, Jenny M ^b   Schneider, Kellie E ^b   Frederick, Peter J ^b   Finan, Michael A ^a   Reed, Eddie ^a   Fauci, Janelle M ^b   Straughn Jr , J Michael ^b   Rocconi, Rodney P ^a  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Deep venous thrombosis; Embolism; Gynecologic malignancy; Prophylaxis

Indexed keywords

ANTIBIOTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ANTIBIOTIC THERAPY; ANTICOAGULANT THERAPY; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DEMOGRAPHY; DRUG EFFICACY; ENDOMETRIUM CANCER; FEMALE; FISTULA; GYNECOLOGY; HEMATOCRIT; HEMATOMA; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LAPAROTOMY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OVARY CANCER; PELVIS ABSCESS; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL INFECTION; TRANSFUSION; UTERINE CERVIX CANCER; WOUND DEHISCENCE;

ALABAMA; ANTICOAGULANTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; INTERMITTENT PNEUMATIC COMPRESSION DEVICES; LAPAROTOMY; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 83055196834     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31821dc9f0     Document Type: Article

References (24)

1. Centers for Disease Control Healthcare Professionals: Data and Statistics. Available at: http://www.cdc.gov/ncbddd/dvt/hcp-data.htm. Accessed February 1, 2011.
2. Crandon AJ, Knotts J. Incidence of postoperative thrombosis in gynecologic oncology. Aust NZ J Obstet Gynaecol. 1983;23:216Y219. (Pubitemid 14158911)
3. Clarke-Pearson DL, Jelovsek FR, Creasman WT. Thromboembolism complicating surgery for cervical and uterine malignancy: incidence, risk factors and prophylaxis. Obstet Gynecol. 1983;61:87Y94. (Pubitemid 13212381)
4. Agnelli G, Bolis G, Capussotti L, et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg. 2006;243:89Y95. (Pubitemid 43054059)
5. Einstein MH, Pritts EA, Hartenbach EM. Venous thromboembolism prevention in gynecologic cancer surgery: a systematic review. Gynecol Oncol. 2007;105:813Y819. (Pubitemid 46734212)
6. Bergqvist D, Agnelli G, Cohen AT, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002;346:975Y980. (Pubitemid 34983247)
7. Einstein MH, Kushner DM, Connor JP, et al. A protocol of dual prophylaxis for venous thromboembolism prevention in gynecologic cancer patients. Obstet Gynecol. 2008;112:1091Y1097.
8. Clarke-Pearson DL, Coleman RE, Synan IS, et al. Venous thromboembolism prophylaxis in gynecologic oncology: a prospective, controlled trial of low-dose heparin. Am J Obstet Gynecol. 1983;145:606Y613. (Pubitemid 13149421)
9. Clark-Pearson DL, DeLong E, Synan IS, et al. controlled trial of two low-dose heparin regimens for the prevention of postoperative deep vein thrombosis. Obstet Gynecol. 1990;75:684Y689. (Pubitemid 20110192)
10. Clarke-Pearson DL, DeLong ER, Synan IS, et al. Complications of low-dose heparin prophylaxis in gynecologic oncology surgery. Obstet Gynecol. 1984;64:689Y694. (Pubitemid 15205477)
11. Clark-Pearson DL, Synan IS, Dodge R, et al. A randomized trial of low-dose heparin and intermittent pneumatic calf compression for the prevention of deep venous thrombosis after gynecologic oncologic surgery. Am J Obstet Gynecol. 1993;168:1146Y1153.
12. Maxwell GL, Synan IS, Dodge R, et al. Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery: a randomized trial. Obstet Gynecol. 2001;98:989Y995. (Pubitemid 34075320)
13. Baykal C, Al A, Demirtas E, et al. Comparison of enoxaparin and standard heparin in gynaecologic oncologic surgery: a randomised prospective double-blind clinical study. Eur J Gynaecol Oncol. 2001;22:127Y130. (Pubitemid 32963064)
14. Borstad E, Urdal K, Handeland G, et al. Comparison of low molecular weight heparin vs. unfractionated heparin in gynecological surgery. Acta Obstet Gynecol Scand. 1988;67:99Y103.
15. Fricker JP, Vergnes Y, Schach R, et al. Low dose heparin versus low molecular weight heparin (Kabi 2165, Fragmin) in the prophylaxis of thromboembolic complications of abdominal oncological surgery. Eur J Clin Invest. 1988;18:561Y567. (Pubitemid 19041520)
16. Kaaja R, Lehtovirta P, Venesmaa P, et al. Comparison of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin, with or without dihydroergotamine, in abdominal hysterectomy. Eur J Obstet Gynecol Reprod Biol. 1992;47:141Y145.
17. von Tempelhoff GF, Harenberg J, Niemann F, et al. Effect of low molecular weight heparin (Certoparin) versus unfractionated heparin on cancer survival following breast and pelvic cancer surgery: a prospective randomized double-blind trial. Int J Oncol. 2000;16:815Y824.
18. Martino MA, Williamson E, Rajaram L, et al. Defining practice patterns in gynecologic oncology to prevent pulmonary embolism and deep venous thrombosis. Gynecol Oncol. 2007;106:439Y445. (Pubitemid 47302465)
19. Shojania KG, Duncan BW, McDonald KM, et al. Making health care safer: a critical analysis of patient safety practices. Evid Rep Technol Assess (Summ). 2001;iYx, 1Y668.
20. Morgan MA, Iyengar TD, Napiorkowski BE, et al. The clinical course of deep vein thrombosis in patients with gynecologic cancer. Gynecol Oncol. 2002;84:67Y71. (Pubitemid 34056469)
21. Levitan N, Dowlati A, Remick SC, et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore). 1999;78:285Y291. (Pubitemid 29439263)
22. Sorensen HT, Mellemkjaer L, Olsen JH, et al. Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000;343:1846Y1850. (Pubitemid 32104130)
23. Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med. 2000;160:3415Y3420.
24. Hansson PO, Eriksson H,Welin L, et al. Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: the study of men born in 1913. Arch Intern Med. 1999;159:1886Y1890. (Pubitemid 29424708)